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Recurrent focal glomerulosclerosis: Natural history and results of treat- proliferative lupus nephritis (n 5 16), CD134L was found to be abun-
dantly present in a predominant distribution along the glomerularment with plasmapheresis. M.B. Andresdottir, N. Ajubi, K.J.M. Ass-
mann, L.B. Hilbrands, and J.F.M. Wetzels. Department of Nephrology, capillary wall in association with immune deposits, as determined by
immunohistochemistry with a CD134-containing chimeric molecule.University Hospital Nijmegen, The Netherlands. Approximately 30%
of patients with focal glomerulosclerosis (FGS) experience a recurrence In none of the other renal disorders examined (n 5 54), including non-
proliferative forms of lupus nephritis (n 5 7), glomerular distribution ofof the original disease after renal transplantation, which can lead to
persisting proteinuria and eventually to graft loss. There is evidence CD134L was found in a similar pattern. Vasculitis was frequently
associated with extraglomerular endothelial expression of CD134L.that proteinuria disappears after treatment with plasmapheresis (PF).
We have studied the course of recurrent FGS after renal transplanta- CD134 was detected on leukocytes in perivascular infiltrates and also
on the epithelium in a distinct segment of the tubules, but not ontion in our center. Ten patients (6m/4f) who have received a kidney
graft in the period between 1973 and 1991 were not treated with PF. glomerular resident cells. Whereas all cases examined showed glomeru-
lar expression of TNF receptor 2, TNF receptor 1 was strongly ex-The diagnosis of recurrent FGS (defined as proteinuria . 3.5g/24hrs)
was made at a median of 10 days (range 0–136 days) after transplanta- pressed in proliferative lupus nephritis only, in a similar distribution
as found for CD134L. We hypothesize that CD134L can be producedtion. In all recipients but one, the heavy proteinuria persisted, and
eventually all grafts were lost, on average 43 months after the diagnosis by glomerular visceral epithelial cells and will further investigate its role
in normal renal physiology as well as in the pathogenesis of proliferativeof the recurrence. In five of these patients the recurrence was the
single cause of graft loss. Since 1991 we have treated 7 patients (5m/ lupus nephritis. Detection of CD134L may have diagnostic value in
distinguishing proliferative from non-proliferative forms of lupus ne-2f) with a recurrence of FGS with PF. These patients also developed
the recurrence at 10 days after transplantation. The PF treatment was phritis. Key word: Immunologie
initiated 9 days (range 0–50 days) after the diagnosis of a recurrence
was made. In three patients the recurrence of FGS was accompanied
by an acute rejection. Despite antirejection therapy, the rejection led Systemic and renal hemodynamic effects of different doses of L-NAME
in humans. A. Broere, A.H. van den Meiracker, F. Boomsma, F.H.M.to graft failure in two of these cases. In the remaining five patients,
however, the treatment with PF resulted in disappearance of the pro- Derkx, M.A.D.H. Schalekamp, and A.J. Man in t’Veld. Department
of Internal Medicine I, University Hospital Dijkzigt, Rotterdam, Theteinuria, and in three of them the response was lasting (follow-up
1.1–2.1 years). In two patients, the proteinuria recurred after stopping Netherlands. The aim of this study was to explore whether in humans
the renal circulation is more sensitive to the effects of NO synthesisthe PF treatment. Currently, these two patients are successfully being
treated (proteinuria; 0.64 and 1.52 g/24hrs respectively) with PF once inhibition than other vascular beds. Therefore the effects of three
different i.v. infusions of L-NAME (1, 5 and 25 mg/kg.min for 30every 3 weeks. Conclusion: A recurrent FGS is characterized by a
persistent proteinuria, and leads to graft failure in at least 50% of the minutes) or placebo on mean arterial pressure (MAP), systemic vascu-
lar resistance (SVR), glomerular filtration rate (GFR), renal bloodrecipients. Treatment with PF often leads to a disappearance of the
proteinuria. A prolonged follow-up is needed to evaluate if treatment flow (RBF), renal vascular resistance (RVR), and fractional sodium
and lithium excretion (FENa, FELi) were studied in 12 healthy subjects.with PF also can lead to an improved graft survival. Key word: trans-
plantatie Each of them received randomly 2 of the 4 treatments. MAP was
measured continuously with the Finapres device and stroke volume
was calculated by means of a model flow method. GFR and RBF were
estimated from the clearances of radiolabeled thalamate and hippuran.Strong and selective glomerular localization of CD134-ligand and TNF
receptor 1 in proliferative lupus nephritis. J. Aten, A. Roos, N. Claessen, Measurements were continued until 90 minutes after the end of the
infusions. During placebo renal and systemic hemodynamics and frac-E.J.M. Schilder-Tol, I.J.M. ten Berge, and Jan J. Weening. Departments
of Pathology and Internal Medicine (Renal Transplant Unit), Academic tional excretion of sodium and lithium did not change. With the low
and intermediate dose of L-NAME there were similar increments inMedical Center, University of Amsterdam, Amsterdam, The Nether-
lands. CD134 (OX40) is a member of the TNF receptor family and renal and systemic vascular resistance, respectively 20.4 6 19.6 and
23.5 6 16.0% with the low and 31.4 6 26.7 and 31.2 6 14.4% withcan be expressed on activated T lymphocytes. Interaction between
CD134 and its ligand (CD134L) is involved in costimulation of T and the intermediate dose (mean 6 SD). With the high L-NAME dose
RVR increased more than SVR. Despite a decrease in renal bloodB lymphocyte activation, and in T cell adhesion to endothelium. In
an experimental model for drug-induced SLE-like autoimmunity, we flow FENa and FELi did not change with the low dose, but they decreased
by 31.2 6 11.0 and 20.2 6 6.3% with the intermediate and 70.8 6 8.1have observed enhanced expression of CD134 on a subset of activated T
lymphocytes. In order to examine the possible role of CD134-CD134L and 31.5 6 15.9% with the high dose. The decrements of FENa and
FELi were correlated with the rise of the filtration fraction. Asinteractions in the pathogenesis of SLE, we studied expression of
CD134 and CD134L on peripheral blood leukocytes, revealing no L-NAME did not have a preferential effect on the renal vascular bed,
it is concluded that in humans the NO mediated vasodilator tone insignificant differences between SLE patients (n 5 12) and control
individuals (n 5 14). However, in all renal biopsies of patients with the renal circulation is not greater than in the systemic circulation.
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The higher threshold dose of L-NAME for antinatriuresis as compared age, sex, classical risk factors and serum total homocysteine (OR (95%
to the threshold for decrease of renal blood flow suggests that antinatri- CI); 1.20 (1.08 to 1.32)). Conclusion. Both hyperhomocysteinemia and
uresis is caused by hemodynamically induced pertubuler alterations protein intake are related to microalbuminuria independent of
of peritubular forces and that renal tubular sodium reabsorption is not NIDDM and hypertension. Hyperhomocysteinemia may partly explain
under direct NO control. Key word: physiology the link between MA and increased risk of cardiovascular disease.
Regulation by aldosterone of the amiloride-sensitive sodium channel Atrial Natriuretic Peptide increases albuminuria in type 1 diabetic
in rabbit connecting and cortical collecting tubules. E.J.W. Dijkink, patients: evidence for blockage of tubular protein reabsorption. E.M.G.
A. Hartog, P. Deen, C.H. van Os, and R.J.M. Bindels. Dep. of Cell Jacobs, G. Vervoort, A.J.W. Branten, P. Smits, and J.F.M. Wetzels.Physiology, University of Nijmegen, The Netherlands. The luminal ami-
Departments of Internal Medicine and Nephrology, University Hospital,loride-sensitive Na1 channel forms the rate-limiting step in Na1 reab-
Nijmegen, The Netherlands. A hemodynamic basis for diabetic ne-sorption in the cortical collecting duct. This channel is regulated by
phropathy is suggested by the occurrence of hyperfiltration and glomer-aldosterone and plays an important role in the maintenance of sodium
ular hypertension. The Atrial Natriuretic Peptide (ANP) is a natriuretichomeostasis and blood pressure. The recent cloning of the three homo-
and vasodilating hormone. The most striking renal hemodynamic effectlogues channel subunits denoted a, b and g-epithelial Na1 channels
of ANP is the increase in glomerular filtration fraction (FF) due to(ENaC) has provided a molecular approach to investigate the mecha-
preglomerular vasodilation and postglomerular arteriolar vasoconstric-nism by which aldosterone stimulates Na1 reabsorption in the distal
tion. In diabetes increased plasma levels of ANP have been reportednephron. In the present study, immunodissected rabbit connecting and
and it has been suggested that ANP contributes to the glomerularcortical collecting tubules were cultured to confluence on permeable
hyperfiltration seen in patients with diabetes mellitus. Infusion of ANPsupports. Within a few days an amiloride-sensitive potential difference
developed across the monolayers which is indicative of a polarized increases the urinary excretion of albumin in patients with diabetes.
Na1 transporting monolayer. Addition of aldosterone (1027 M, both Although the increased albuminuria has been attributed to a rise in
sides) increased transepithelial Na1 transport after a lag time of 2–6 glomerular pressure, alterations in tubular protein handling might be
h to a maximum of 260 6 44% of basal value reached after 16 h of involved. We have studied the effects of ANP in 9 micro-albuminuric
incubation. To determine the effect of aldosterone on the transcription patients with type 1 diabetes. After baseline measurements, ANP was
of a, b and g-rbENaC, fragments of these subunits were isolated from infused during 60 minutes at a rate of 0.01 mg/kg/min after a bolus of
a cDNA bank previously generated from these primary cultures. The 0.05 mg/kg. GFR and ERPF were measured by inulin and PAH clear-
reading frame of these fragments started in the extracellular domain ances respectively. Filtration fraction (FF) was calculated by the quo-
at AA number 218, 244 and 498 for the a, b and g-subunit, respectively. tient of GFR and ERPF. Blood pressure was measured by Dinamap.
Homology to the corresponding rat subunits ranged from 84 to 93% Urinary albumin, b2-microglobulin and k-light chain concentrationsat AA level. A radioactive semi-quantitative RT-PCR was developed were measured by an ELISA. Proximal and distal sodium reabsorption
to measure the ENaC subunit mRNA levels after exposure to aldoste- were calculated by the lithium clearance method. Statistical analysisrone. Two different sets of primers, that is primers designed for a, b
was performed by a repeated measures analysis of variance. Valuesor g-rbENaC and human b actin, were used in one PCR and the
are given as means 6 SE. GFR increased from 121 6 9 at baselineamplified two products were of the predicted size of 419, 746 or 234,
to 133 6 8 ml/min (p , 0.05) after infusion of ANP, whereas ERPFrespectively and 328 bp. The relative amount of rbENaC subunits was
decreased from 564 6 50 to 507 6 34 ml/min (p , 0.05). As a conse-calculated from the ratio of the amount of ENaC and b actin fragment.
quence, FF increased from 0.22 6 0.01 to 0.26 6 0.01 (p , 0.01). ANPThe a, b and g-subunit mRNA levels were not changed by aldosterone
attenuated both proximal and distal tubular sodium reabsorption asduring the first 2 h of incubation, but a twofold increase was apparent
assessed by the lithium clearance technique. Urinary excretion of albu-after 6 h. These mRNA levels remained elevated up to 16 h of incuba-
min increased from 87.6 6 21.0 to 29.1 6 67.9 mg/min (p , 0.01). Thetion. In conclusion, aldosterone stimulates sodium transport maximally
urinary excretion of b2-microglobulin increased from 0.28 6 0.21 toafter 6 h of incubation, which is paralleled by an increased a, b and
51.9 6 10.5 mg/min (p , 0.01) and k-light chains from 4.7 6 1.5 tog-rbENaC abundance. Key word: Fysiologie
44.9 6 4.3 mg/min (p , 0.01). During infusion of ANP no significant
changes in blood pressure were seen. Conclusion: ANP increases uri-
Serum homocysteine level and protein intake are related to risk of nary excretion of albumin in micro-albuminuric patients with type 1
microalbuminuria. E.K. Hoogeveen, P.J. Kostense, A. Jager, R.J. Heine, diabetes. Furthermore, ANP attenuates proximal reabsorption of the
C. Jakobs, L.M. Bouter, A.J.M. Donker, and C.D.A. Stehouwer. Insti- low molecular weight proteins b2-microglobulin and k-light chain.
tute for Research in Extramural Medicine, Dpt of Internal Medicine, Therefore, the increase in albuminuria after infusion of ANP might not
Dpt of Clinical Chemistry, University Hospital Vrije Universiteit, Amster- simply reflect changes in glomerular pressure but could be explained by
dam, The Netherlands. Background. Microalbuminuria (MA) is a inhibition of proximal tubular albumin reabsorption.
strong predictor of cardiovascular disease, but its causes are incom-
pletely understood. Hyperhomocysteinemia is a recently recognized
risk factor for cardiovascular disease independent of established risk Benefit of renoprotective therapy in chronic renal failure: role of pre-
factors. It is not known whether hyperhomocysteinemia is associated intervention renal function decline and ACE I/D polymorphism.
with and thus a possible cause of microalbuminuria. Methods. We F.G.H. van der Kleij, G.J. Navis, T.J. Kistemaker, D. de Zeeuw, and
studied an age-, sex- and glucose-tolerance stratified random sample P.E. de Jong. Department of Internal medicine, Division of Nephrology,of a 50–75 year-old general Caucasian population (n 5 680). The
Department of Clinical Pharmacology, State University of Groningen,urinary albumin-to-creatinine ratio (ACR) was measured in an early
Groningen, The Netherlands. In chronic renal failure rate of renalmorning spot urine sample. MA was defined as ACR . 3.0 mg/mmol.
function loss varies widely between patients. To evaluate the effect ofResults. The prevalence of MA was 4.3% (13/304) in subjects with
intervention strategies, it would be useful to assess individual renopro-normal glucose tolerance, 9.2% (17/185) in impaired glucose tolerance
tective benefit. We performed an analysis of preintervention courseand 18.3% (30/164) in non-insulin-dependent diabetes mellitus
of renal function in 81 non-diabetic renal patients in whom a 4-year(NIDDM); it was 3.7% (15/402) in subjects without hypertension and
prospective intervention study was performed (enalapril vs. atenolol).17.9% (45/251) in those with hypertension. After adjustment for age,
Data were available in 51 patients (mean pre-trial follow-up of 62sex, glucose tolerance category, hypertension, dyslipidemia and smok-
months, $5 data point, $24 months follow-up). After placebo wash-ing, the odds ratio (OR; 95% confidence interval (95% CI) for MA
out, baseline values (mean 6 95% CI) for creatinine clearance wereper 5 mmol/L total homocysteine increment was 1.33 (1.08 to 1.63).
21.69 ml/min (21.07; 22.30), for MAP 110 (106–113) mmHg andAdditional adjustment for HbA1c, waist-hip ratio, protein intake and
for proteinuria (present in 28 patients) 1.4 (0.9–1.9) g/24h. Duringserum creatinine did not attenuate the association between MA and
intervention, MAP fell by 13.6% (210.9; 215.9) and Uprot by 38.5%total homocysteine. A 0.1 g/kg.day increment of protein intake was
also associated with an increased risk for MA after adjustment for (27.7; 269.3).
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protein diet (0.80 6 0.04 g/kg/d). In contrast, in patients with a baseline
Mean 6 95% CI Pre-intervention Intervention slope P Value ALB $40 g/L (n 5 30) PNA was significantly higher during the high
(1.02 6 0.03 g/kg/d) than during the low protein diet (0.89 6 0.02 g/All patients n551 22.7 (23.5; 21.8) 21.7 (22.3; 21.1) 0.04
kg/d). PNA averaged over the total study period was higher in patientsEnalapril n525 23.2 (24.3; 22.0) 21.7 (22.7; 20.9) 0.11
with a baseline ALB $40 g/L than those with ALB ,40 g/L. In conclu-Atenolol n526 22.2 (23.5; 20.8) 21.6 (22.4; 20.9) 0.52
sion, prescription of a high protein diet plus dietary counseling in stableDD genotype n512 25.4 (27.5; 23.4)* 22.9 (23.8; 22.1)* 0.01
HD patients can increase actual protein intake, but increasing Kt/VeqID genotype n520 21.5 (22.6; 20.4) 21.2 (22.3; 20.3) 0.98
.1.0 does not improve dietary compliance. Patients with a poor NSII genotype n519 22.1 (23.4; 20.9) 21.3 (22.4; 20.3) 0.44
had a relatively low dietary protein intake and were not able to increase
Effect on slope of creatinine clearance (ml/min/yr)
their intake.* P , 0.05; DD vs. ID and II
A slight overall improvement in slope was obtained. Change of slope Mutations in the basolateral chloride-channel (CLCNKB) gene cause
did not correlate with baseline or reduction in MAP or proteinuria. Bartter syndrome. H.H. Lemmink, N.A.V.M. Knoers, R.J. Bindels, M.
A strong correlation was present between pre-intervention slope and Bult, C. Buskens, L.A.H. Monnens, and L.P.W.J. van den Heuvel.
change in slope (r 5 0.77, p , 0.001), i.e. treatment benefit was largest Departments of Pediatrics, Cell Physiology and Human Genetics, Uni-
in patients with a more rapid renal function decline before intervention. versity Hospital Nijmegen, Nijmegen, The Netherlands. Bartter syn-
In ACE DD genotype, rate of renal function decline was more rapid drome (BS) is a hereditary, renal tubular disorder primarily character-
both before and during intervention. Remarkably, a clear treatment ized by hypokalaemic metabolic alkalosis. BS can be clinically
benefit as to change in slope was present only in DD subjects, in spite subdivided into at least two phenotypes; 1) classical and 2) neonatal
of similar reduction in MAP and proteinuria in other genotypes. We variants of Bartter’s syndrome. Recent studies have demonstrated mu-
conclude that renoprotective benefit of antihypertensive intervention tations in the Na-K-2Cl cotransporter (NKCC2) and ROMK genes in
is largest in patients with a higher a priori renal risk. This warrants neonatal BS. In some neonatal/classic Bartter families the involvement
strict blood pressure control in patients with rapid renal function deteri- of both NKCC2 and ROMK genes could be excluded after linkage or
oration, including those with ACE DD genotype. Moreover, in the gene mutation analysis. Therefore the search for mutations in these
design of clinical trials stratification for renal risk should be considered. Bartter patients was continued in the basolateral chloride channel
(CLCNKB) which was supposed to be one of the components involved
in the Na-Cl reabsorption in the thick ascending limb of Henle (TAL).An additional dose of dialysis has no contributory effect on protein After screening a large part of the coding region for mutations by PCR-intake in stable hemodialysis (HD) patients on a high prescribed pro- SSCP analysis we have identified complete CLCNKB gene deletionstein diet: Results of the Groningen Utrecht Dialysis and Diet Study in two patients and a homozygous serine for threonine amino acid(GUDDS). W.D. Kloppenburg, C.A. Stegeman, P. Vos, H. Vastenburg,
substitution (Thr481Ser) in two other unrelated patients. Our resultsT.K. Kremer-Hovinga, P.E. de Jong, and R.M. Huisman. Dept. of
provide tools for molecular diagnosis of Bartter syndrome and increaseMedicine, University Hospital, Groningen, The Netherlands. A Kt/Veq the number of genes involved in Bartter syndrome to a total of three.
5 1.0 is assumed to be an adequate dose of dialysis in stable HD
The possible effect of mutations in individual genes will be discussedpatients. However, protein intake is frequently low and nutritional
and indicates that functional analysis of these gene mutations is neces-status (NS) is reported to be poor in these patients, despite an adequate
sary to test their effect and clarify their role in the array of clinicaldialysis dose. Although intensive dietary counseling can increase pro-
features identified in patients with Bartter syndrome.tein intake, it is not known whether increasing the dialysis dose .1.0
Kt/Veq has a contributory effect. This study was performed to evaluate
the effect of the dialysis dose and dietary protein prescription on actual
Immunohistochemical analysis of skin biopsies for diagnosis of patientsprotein intake. 58 Stable, thrice weekly dialyzed HD patients were
with Alport Syndrome. F.T.L. van der Loop, L.A.H. Monnens, C.H.randomised into a group with a high Kt/V (target Kt/Veq 5 1.4), and
Schro¨der, E.D.J. Timmer, H.H. Lemmink, and H.J.M. Smeets. Dept. ofa normal Kt/V (target Kt/Veq 5 1.0). All patients were prescribed a
Genetics, University of Maastricht, and Depts of Pediatric Nephrology,high protein diet (target DPI 5 1.3 g/kg ideal body weight (IBW)/d)
Universities of Nijmegen and Utrecht, The Netherlands. The Glomerularand low protein diet (target DPI 5 0.9 g/kg IBW/d) with adequate
Basement Membrane (GBM) contains two collagen IV networks: theenergy content during 2 3 40 weeks in a time-controlled, randomised,
first consists of heterotrimers of COL4A1 and COL4A2 chains,cross-over design. Plasma albumin (ALB) was used as an index of NS.
whereas the second consists of COL4A3, COL4A4 and COL4A5. ThisKt/Veq, protein nitrogen appearance (PNA), and ALB were measured
latter network is affected in Alport syndrome (AS), a clinically andevery 5 weeks. Actual dietary protein (DPI) and energy (ENI) intake
genetically heterogenous inherited disorder of the GBM. Characteristicwere estimated from food records kept every 10 weeks. Data of patients
features are hematuria, progressive renal failure and sensorineuronalwith a minimum follow-up of 10 weeks (n 5 50) were analyzed. Age
(56 6 15 yrs [mean 6 SD]), time on HD (48 6 52 mths), and follow- hearing loss. Electron microscopic analysis of the GBM is used to
up (65 6 25 wks) did not differ among the groups. Averaged values confirm the clinical diagnosis. About 85% of the Alport patients are
obtained during the study are shown. expected to carry a mutation in the X-chromosomal COL4A5 gene
(XL-AS patients), and 15% in the autosomal COL4A3 and COL4A4
genes (AR-AS). At this point mutation analysis is extremely laborious
and only half of the mutations are detected. It is estimated that aboutHigh (1.4) Normal
Kt/Veq 70% of the COL4A5 mutations lead to the absence of this chain from
protein diet High (1.3) Low (0.9) High (1.3) Low (0.9) the GBM. COL4A5 is, in contrast to COL4A3 and COL4A4, also
present in the Epidermal Basement Membrane (EBM). It is likely thatKt/Veq g/kg/d 1.2960.11† 1.33 60.11† 1.02 60.08 1.04 60.07
a mutation that causes the absence of COL4A5 from the GBM alsoPNA g/kg/d 1.060.16‡ 0.8760.09 0.95 60.20‡ 0.87 60.16
results in the absence of this chain from the EBM. Skin biopsies ofDPI g/kg/d 1.2060.17‡ 0.94 60.10 1.10 60.20‡ 0.94 60.11
10 AS patients, 2 Familial Benign Hematuria (FBH) patients and 4ENI kcal/kg/d 30 65‡ 28 64 29 66 28 65
possible AS patients have been tested by collagen IV chain specificALB g/L 42 63 42 63 42 63 42 63
immunostaining. The exact mutations in 5 of these patients (3 COL4A5,
† p , 0.05 vs Normal Kt/V, unpaired t-test; ‡ p , 0.05 vs LOW protein diet, 1 COL4A3 and 1 COL4A4) were already characterized. In 5 AS pa-paired t-test
tients the COL4A5 chain was lacking in the EBM. A patient with
AR-AS, as well as 2 FBH patients showed a normal staining pattern.
No false diagnosis was made. In one patient from the group of possiblePrescription of a high protein diet did increase actual protein intake
AS patients the diagnosis XL-AS was established. In summary, immu-to a small extent, but increasing Kt/Veq . 1.0 had no contributory
nohistochemical analysis of skin biopsies of patients can be used foreffect. Interestingly, in patients with a baseline ALB ,40 g/L (n 5
12) PNA did not differ between the high (0.84 6 0.06 g/kg/d) and low diagnosis of XL-AS much faster and with a higher score than is cur-
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rently possible by mutation analysis, thereby saving the patient a kidney mans, and W. Weimar. Department of Internal Medicine I, University
Hospital Rotterdam-Dijkzigt and Department of Epidemiology and Bio-biopsy. Key word: overig
statistics, Erasmus University Rotterdam, The Netherlands. The growing
discrepancy between the number of patients waiting for a kidney trans-
plant and the number of donor kidneys could raise questions on theActivation of monocytes correlates with disease activity in patients
allocation of the available organs to the elderly. In all studies regardingwith Wegener’s granulomatosis. A.C. Muller Kobold, C.G.M. Kallen-
the influence of age, it was studied as a categorical variable. We studiedberg, and J.W. Cohen Tervaert. Dept. of Clinical Immunology, Univer-
age both as a categorical (Kaplan-Meier) and as a continuous (Cox)sity Hospital Groningen, The Netherlands. Wegener’s granulomatosis
variable in all 509 CsA treated recipients of a primary cadeveric kidneyis an inflammatory disorder characterized by granulomatous inflam-
graft transplanted between July 1983 and July 1997. For the Kaplan-mation and vasculitis, and is strongly associated with anti neutrophil
Meier analysis the population was divided into three comparablecytoplasmic antibodies (ANCA). Activated monocytes/macrophages
groups: 17–43 years (n 5 171), 44–55 years (n 5 169) and 56–75 yearsparticipate in granuloma formation by synthesizing and secreting a
(n 5 169). Patient survival was better but functional graft survivalvariety of chemoattractants, growth factors and cytokines. In view of
(censored for death) was worse in the younger patients. However,these findings, we evaluated in vivo monocyte activation in patients
over-all graft survival (uncensored for death) was not significantlywith WG and related our findings to parameters of clinical disease
influenced by age. In the Cox proportional hazards analysis the yearactivity. Monocyte activation was analysed by measuring plasma levels
of transplantation turned out to be an independent variable influencingof soluble products of monocyte activation, that is neopterin and
patient survival, functional graft survival and over-all graft survival.interleukin-6, by ELISA, and by quantitating the surface expression of
As the influence was not linear, three periods were defined in whichactivation markers on circulating monocytes by flowcytometry. Twenty
the relative risk was stable: 1983–1990, 1991–1993 and 1994–1997. Infour patients with active WG were included in this study. Ten of these
the second period the relative risk for transplant failure or death waspatients were also analysed at the time of remission. Twelve patients
54% of that in the first period. In the third period the relative riskwith sepsis served as positive controls, and 10 healthy volunteers as
had decreased even further to 22% of that in the first period. Acceptornegative controls for monocyte activation. Patients with active disease
age was also a significant predictor of over-all transplant failure. Therehad increased monocyte activation compared to healthy controls as
was no interaction between these variables. There was a linear relation-shown by increased concentrations of neopterin (p , 0.0001) and
ship between recipient age and over-all survival. When adjusted forincreased surface expression of CD11b (p , 0.05) and CD64 (p ,
year of transplantation, an increase in recipient age by one year in-0.05). During follow up plasma concentrations of IL-6 decreased when
creased the relative risk for over-all graft failure by only 1.5%. Never-patients went into remission (p , 0.0001). In addition, neopterin (r 5
theless, a 20-year-old patient transplanted in period 1 turned out to0.36, r 5 0.44), IL-6 (r 5 0.37, r 5 0.6) and CD63 expression (r 5
have the same relative risk as a 60-year-old transplanted in period 2.0.39, r 5 0.45) correlated significantly with disease activity as measured
A 20 year old transplanted in period 2 had the same relative risk asby the BVAS score and CRP values, respectively. We conclude that
a 69-year-old in period 3. Donor age was a significant predictor ofdisease activity in WG correlates with the extent of activation of mono-
over-all transplant survival as well. There was no interaction betweencytes, compatible with their role in the pathophysiology of this disease. donor age and transplantation period either. Within the same trans-
plantation period, there was a J-shaped relationship between donor
age and over-all graft survival, with its minimum at 30 years. However,Urinary excretion of aquaporin-2 in response to different stimuli of the ameliorating results in time significantly surpassed the influenceADH-dependent water reabsorption. M.H.J. van de Pol, R. Baumgar- of donor age. We conclude that considering the improving results in
ten, J.F.M. Wetzels, P.M.T. Deen, and C.H. van Os. Departments of Cell time, the influence of donor and recipient age has become an issue of
Physiology and Nephrology, Faculty of Medical Science and University relatively minor importance.
Hospital Nijmegen, The Netherlands. Water transport in the collecting
tubules of the kidney is mediated through the ADH-regulated water
channel Aquaporin-2 (AQP2). We questioned whether the urinary Conversion of cyclosporine (neoral; CsA) to mycophenolate mofetil
excretion of AQP2 (UAQP2) is a reflection of the stimulation of ADH- (MMF) in stable renal transplant recipients. Y.C. Schrama, R.J. Hene´,
dependent water transport. To this end we have studied the urine P. Boer, and H.A. Koomans. University Hospital Utrecht, The Nether-
osmolality (Uosm) and the UAQP2 in normal subjects, under three lands. In order to investigate efficacy and safety of the combination
conditions: overnight dehydration, continuing in the daytime, the infu- of MMF and prednisone (pred) in comparison to CsA and pred in
sion of hypertonic saline (700 ml 2.5% NaCl in 45 min), or the adminis- renal transplant recipients we performed an open prospective study
tration of DDAVP (40 mg intranasally). Urine samples were concen- with the patient being his own control. Methods: 17 stable patients
trated and equivalents of 4 mmol creatinine were analyzed by a Western were investigated; all more than 6 months after renal transplantion
blot assay and semi-quantified using a co-immunoblotted dilution series (range 7–117 months). At start of the study they used CsA (mean
of BSA-AQP2 as a standard. The detectable amount of UAQP2 is trough level 130 6 30 mg/L) and prednisone 7.5 mg od. After the first
expressed as ng BSA-AQP2/mmol creatinine. When combining the measurements MMF 1 gr bid was given and CsA slowly tapered to a
data of all study days we found a weak but significant correlation mean trough level of 50 6 10 mg/L. When no signs of rejection were
between baseline Uosm and UAQP2 (r 5 0.60, p , 0.05). After over- noted after a period of 8 wks at low dose CsA, the CsA was slowly
night dehydration urine osmolality increased from 888 6 18 mosm/kg withdrawn. At three time points the patients were investigated: At
start with a normal dose of CsA, after 8 wks of low dose CsA and 8at baseline to 1004 6 17 mosm/kg after 6 hours. In parallel, UAQP2
wks after stopping CsA. We performed inulin and hippurate clearanceincreased from 0.38 6 0.12 to 0.78 6 0.12 ng/mmol create. In response
studies for investigation of glomerular filtration rate (GFR), renalto the administration of DDAVP Uosm increased from 101 6 17 to
860 6 30 mosm/kg, with a parallel increase in UAQP2 from 0.07 6
0.03 to 0.98 6 0.19 ng/mmol creat. The infusion of 2.5% NaCl resulted Normal Low dose
in a more modest increase in Uosm from 78 6 8 to 352 6 75 dose CsA CsA No CsA
mosm/kg. In this condition no major change in UAQP2 was observed,
MAP (mm Hg)* 113.6 113.7 108.3 #%with maximum levels of 0.02 6 0.01 ng/mmol create. In conclusion: the
GFR (ml/min) 46 68 51 611 && 57 611 ##%%urinary excretion of AQP2 is increased only in conditions of maximally
RBF (ml/min) 435 699 490 6137 490 6171stimulated water transport. The mechanisms of this increased AQP2
RVR (mm Hg.min/L) 0.29 60.06 0.26 60.08 0.26 60.10excretion remain to be clarified. In contrast, the urinary excretion
Uric acid (mmol/L)* 0.43 0.36 && 0.32 ##%%of AQP2 does not reflect ADH dependent water transport under
Total chol (mmol/L) 6.29 61.11 5.92 61.11 & 5.75 60.97 #%submaximally stimulated conditions. Therefore it is unlikely that uri-
LDL chol (mmol/L) 3.20 60.60 3.28 60.84 3.41 60.76nary excretion of AQP2 can be used to study ADH-dependent water
transport under more physiological conditions. Key word: Physiology All values are mean 6 sd, except *(median).
P , 0.05 resp.
P , 0.01 one resp.
The influence of age on kidney transplant survival. J.I. Roodnat, R. # No CsA vs normal dose; % No CsA vs low dose & Low vs normal dose
CsA.Zietse, J. Rischen-Vos, T. van Gelder, P.G.H. Mulder, J.N.M.I. Jzer-
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blood flow (RBF) and renal vascular resistance (RVR). Furthermore (HSA) after 30 min, at concentrations of 50 or 6.25 g/l buffer, could
restore EDR. HSA (50 g/l) restored EDR to 50% at LPC levels of 5,we measured 24 h blood pressure (mean arterial pressure, MAP),
blood uric acid and the lipid profile. Sodium intake was not changed. 10, 20 and 30 mg/ml and to 25% at 40 and 50 mg/ml. Furthermore,
6.25 g/l HSA also restored EDR to 55% at LPC levels of 30 mg/mlResults: 15 of the 17 patients could be converted successfully. One
showed a steroid responsive rejection after 16 wks of MMF therapy, and to 38% at 50 mg/ml. Thus, albumin could restore EDR in rings
exposed to LPC at a concentration that is quite low, at least in vitro.being on low dose CsA for 7 wks. Another patient was withdrawn
after 9 weeks of MMF because of severe diarrhoea. No restoration by HSA was observed at 100 mg/ml. Third, we tested
whether adding 50 g/l HSA after 10 min and reducing LPC incubationConclusion: In the majority of patients conversion of CsA/pred to
MMF/pred was safe and gave an improvement of renal hemodynamics, to only 30 min had a different effect on the EDR. Now, restoration
of EDR was slightly improved. Finally, we reversed the pre-incubation,BP, serum uric acid. Key word: Transplantation
i.e., rings were first incubated with HSA, followed by LPC after 30
min. Higher LPC concentrations were needed to block EDR. EDR
was restored by 50 g/l HSA to 57% at LPC levels of 300 mg/ml, toA rabbit model of sham-dialysis which allows determination of dialysis-
induced changes in leukocyte-endothelium interactions in vivo. M.E. 24% at 400 and 500 mg/ml, and to 14% at 700 and 1000 mg/ml. However,
6.25 g/l HSA could only restore EDR to 44% at LPC levels of 100van Teijlingen, P. Borgdorff, M.H. van Wijhe, A.A. van Lambalgen,
P.M. ter Wee, and G.J. Tangelder. Laboratory for Physiology and mg/ml and to 17% at 200 mg/ml. Restoration was completely blocked
by 300 mg/ml LPC in 6.25 g/l HSA. In conclusion, LPC-induced inhibi-Department of Nephrology, Institute for Cardiovascular Research
(ICaR-VU), Free University, Amsterdam, The Netherlands. Blood mem- tion of EDR in rat aorta is substantial at and above 20 mg/ml. EDR can
be protected by prior addition of albumin and salvaged by subsequentbrane interactions during hemodialysis (HD) affect leukocyte-endothe-
lium interactions in vitro. To visualize the latter in vivo, we developed addition of albumin, suggesting that normalization of hypoalbumi-
nemia may directly reduce the risk of atherosclerosis in the nephrotica rabbit model of sham-HD combined with intravital videomicroscopy
using conventional dialysis equipment. Blood flow was 12.5 ml/min. syndrome. Characteristics of the protection suggest that LPC is located
in compartments that have a different accessibility to albumin. KeyThe number of perfused capillaries was limited by insertion of a silicone
ring into the dialyzer. No dialysate flow was used. Approximated ratios word: fysiologie
of membrane area to blood volume (4 cm2/ml), extracorporeal volume
to blood volume (0.09) and blood flow to cardiac output (0.03) were
similar to those in clinical HD. The increase in circulatory volume due Safety, side effects and feasibility of dobutamine-atropine stress echo-
cardiography for assessment of coronary artery disease in patients withto the extracorporeal circuit was compensated by administration of
gelofusine. Nevertheless, mean arterial blood pressure fell immediately end-stage renal function requiring hemodialysis. D. Poldermans, R.
van Dorpel, R. Rambaldi, A. van de Meiracker, J.J. Bax, and R. Zietse.after the start of sham-HD reaching a maximal dip of 27 6 10.4% (mean
6 SD) within 5 minutes. Circulating leukocyte counts had dropped with Erasmus University, Rotterdam, The Netherlands. Objective: To assess
safety, side effects and feasibility of dobutamine-atropine stress echo-69 6 9.7% at 10 minutes after the start of sham-HD. Thereafter,
leukocyte counts increased again reaching 99 6 21.4% of baseline levels cardiography (DSE) in patients with end-stage renal function requiring
hemodialysis. Background: DSE is increasingly used for the diagnosiswithin 1 hour. Intravital microscopy of the mesenteric microcirculation
showed that leukocyte rolling along the vascular endothelium was of coronary artery disease (CAD). Methods: Patients were studied
with DSE using incremental doses of dobutamine, starting with 5 upalmost abolished during the period of leukopenia. Moreover, neither
in postcapillary venules nor in arterioles sticking leukocytes were ob- to 40 mg/kg/min, if necessary, to achieve 85% of age and sex predicted
maximal heart rate, in absence of signs or symptoms of ischemia orserved. This indicates that the mesentery is not a side of leukocyte
sequestration. In conclusion, our rabbit model of sham-HD, which side effects. Atropine (up to 2 mg) was added in sub-maximal heart
rate increment. At rest and at the end of every dose step heart rate,involves the use of adapted conventional dialysis equipment, provides
a tool for further studies of HD-induced changes in leukocyte-endothe- blood pressure and echographic images were recorded. There was
continuous 12-lead ECG monitoring. Echo images of the left ventriclelial adhesive interactions in vivo.
were scored using a 16-segment model and a 5-point score (1 5 normal,
2 5 mild hypokinesia, 3 5 severe hypokinesia, 4 5 akinesia, and 5 5
Albumin reverses lysophosphatidylcholine-induced inhibition of endo- dyskenisia) at rest and at peak stress. Ischemia was present if a worsen-
thelium-dependent vasodilation in rat aortic rings. T.D. Vuong, D. ing of wall motion occurred (NWMA) during stress. Results: 57 patients
van Heuven-Nolsen, T.J. Rabelink, H.A. Koomans, and J.A. Joles. were studied, a previous MI was present in 31, angina pectoris in 28
Nephrology, Medical Faculty & Pharmacology, Pharmacy Faculty, patients. Test end-point was: 1) target heart rate 48 (84%), side effects
Utrecht, The Netherlands. Lysophosphatidylcholine (LPC) is an ampho- 7 (12%), and maximal dose dobutamine/atropine 2 (4%). Side effects
phil which is present in oxidized low-density lipoprotein (LDL). Several causing interruption of test were: hypotension (decrease of SBP .40
atherogenic effects of oxidized LDL have been attributed to LPC. One mmHg) in 4, hypertension (SBP .220 mmHg) in 2 and sustained
of these is impairment of endothelium-dependent relaxation (EDR). ventricular tachycardia in 1. During DSE angina occurred in 5 (9%),
Albumin avidly binds LPC. Hence, hypoalbuminemia may directly ST changes in 13 (23%), and NWMA in 15 (27%). The overall incidence
impair EDR and thus contribute to the increased risk of atherosclerosis of hypotension was 15 (27%) (decrease of SBP 10–30 mmHg: 5 (9%)
in hypoalbuminemic patients with the nephrotic syndrome. Addition and .30 mmHg 10 (18%)) and cardiac arrhythmias in 2 (4%) (sus-
of albumin causes a reduction of LPC uptake into endothelial cells. tained and non sustained ventricular tachycardia). In most patients
Therefore, we hypothesized that addition of albumin will restore EDR hypotension was a-symptomatic and did not cause interruption of the
in rat aortic rings exposed to LPC. Aortic rings from male Sprague- test. There were no fatal complications or MI. Conclusions: In patients
Dawley rats were incubated for 90 min with concentrations of LPC with end-stage renal failure DSE for assessment of CAD is safe and
ranging from 0 to 100 mg/ml buffer. Relaxation with acetylcholine feasible in 84% of the patients. Hypotension was the most frequent
(ACH; 1028, 1026, and 1024 M), was studied under isometric conditions occurring side effect.
in the presence of indomethacin (1025 M), after precontraction with
phenylephrine (PE). Rings incubated with 30 or 50 mg/ml LPC showed
enhanced PE-mediated contraction compared to CON. Thus, rings Cytokine mRNA expression and levels in end-stage renal failure and
renal replacement therapy. I.C. van Riemsdijk, E.H.M. Loonen, C.C.incubated with LPC were contracted at lower PE concentration than
CON (3*1027 m for CON rings; 3*1028 m for rings incubated with LPC). Baan, R. Zietse, and W. Weimar. Dept. of Internal Medicine, University
Hospital Rotterdam-Dijkzigt, The Netherlands. Patients with ESRFFirst, we determined the effect of incubation with LPC on ACH-
mediated relaxation. ACH (1026 M)-mediated relaxation was reduced suffer from general immunodeficiency, resulting in susceptibility for
infections and a decreased response on T-cell dependent antigens, suchfrom 65% of the initial precontraction, to 43%, 40% and 32% at LPC
levels of 5, 10 and 20 mg/ml respectively (P , 0.05), and completely as hepatitis B vaccination. Cytokines play a central role in activation
of the immune system. In this study we measured cytokine-mRNA-blocked at and above 30 mg/ml (P , 0.01). Relaxation by (SNP; 1025
M) was complete at all LPC levels, confirming that LPC inhibits EDR profiles in peripheral blood mononuclear cells (PBMC), in order to
find out, whether their immunodeficiency could be linked to a defectin our set-up. Second, we tested whether adding human serum albumin
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in their cytokine gene expression. Patients: in stable pre-dialysis ESRF mediates may induce toxic effects within the peritoneal cavity directly
or indirectly by the formation of AGEs.(n 5 10), on CAPD (n 5 10) and CIHD (n 5 15), we measured
mRNA-expression of IL-1b, IL2, IL4, IL6, IL10, IL15, TNF-a and
IFN-g. Measurements were performed using the RT-PCR method. 11
healthy subjects served as controls. Results: mRNA-expression for Hemodynamics in profiled hemodialysis when a sodium balance is
used. B. Straver, P.M.J.M. de Vries, A.J.M. Donker, and P.M. ter Wee.IL-2 (not detectable) and IFN-g (73% vs 90–100%) was comparable
in PBMC of controls and patients. However, significantly more patients Academic Hospital Vrije Universiteit, Amsterdam, The Netherlands.
Many studies claim less intradialytic hypotension to occur during pro-had positive mRNA-expression of IL-1b, IL-4 and IL-6 compared to
controls (table). filed hemodialysis. The benefit of the described profiles seems to result
from a positive sodium balance which, however, increases the risk of
interdialytic complications, such as hypertension and increased weight
gain. To gain further insight in hemodynamics during different profiles,IL-1b IL-4 IL-6 IL-10
a standard dialysis (S-HD) was compared to a decreasing Na-profiled
Controls 18 27 18 36 dialysis (Na-HD), a UF-profiled dialysis (UF-HD), and a hemodiafil-
ESRF 100* 75* 20 70 tration (HDF) in 8 stable hemodialysis patients. Care was taken to
CAPD 90* 80* 30 80 equalize the sodium balances during all sessions. During dialysis cardiac
CIHD 100* 50 87* 60 performance was monitored by means of electrical impedance cardiog-
raphy, variation in blood volume by means of an on-line optical probe,Percentage positive samples with RT-PCR; *p , 0.01
and hydration state by means of body impedance analysis. The sodium
balance and the mean arterial sodium concentration were similar in
As in most samples of both patients and controls mRNA expression the four treatments. The UF-HD and the HDF did not show any
for TNA-a and IL-15 was present, we performed a quantitative RT- significant effect on intradialytic blood pressure variation compared
PCR for these cytokine genes and found significantly more IL-15 and to S-HD. As a result from a less pronounced decrease in SV, the
TNF-a in patients compared to controls (p 5 0.03, p , 0.001, respec- Na-HD tended to improve blood pressure preservation slightly, al-
tively). Conclusion: we were not able to correlate the general immune though it never reached significance (see Table).
deficiency of ESRF, CAPD or CIHD patients with a deficient expres-
sion of cytokine genes. On the contrary, our data suggest an activation
rather than a suppression of the immune system at the mRNA level. S-HD UF-HD Na-HD HDF
This implies that other factors, e.g. directed at the protein production
No balance 2362666 2440668 2359638 2390641or at the bioavailability of cytokines, play the major role in the immuno-
[Na]art 140.160.7 140.060.7 140.860.6 141.660.6suppressive state of ESRF, CAPD and CIHD patients. Key word:
dMAP (%) 214.665.9 210.265.4 26.765.5 211.463.6dialysis
dSVR (%) 0.7 69.8 24.967.7 24.968.6 10.0614.3
dCO (%) 211.069.1 21.669.3 1.768.1 210.8611.1
dSV (%) 221.167.2 212.369.6 210.966.1 215.2611.1Detection of glucose degradation products in peritoneal dialysis solu-
dHR (%) 12.8 64.9 13.462.6 14.865.6 6.863.8tions. C.G. Schalkwijk, N. Posthuma, P.M. ter Wee, and T. Teerlink.
dBV (%) 26.361.7 26.261.2 25.261.9 27.461.2Department of Clinical Chemistry and Nephrology, Academic Hospital
of the Free University, Amsterdam, The Netherlands. Peritoneal dialysis All values are expressed as their mean 6 SEM.
is a treatment based on the exchange of fluid between the abdominal
cavity and the microcirculation of the peritoneum. Conventional glu-
cose-based solutions are characterized by the presence of toxic com- Sodium balanced Na-HD, UF-HD, and HDF have no significant bene-
pounds, which has been related to the sterilization process, and may ficial effect on intradialytic blood pressure preservation in stable pa-
contribute to the detrimental effects associated with peritoneal dialysis. tients, although some effect on cardiac performance may be attributed
The glucose degradation products such as 3-deoxyglucosone (3-DG), to the sodium profile. When applying a profiled dialysis, reassurances
glyoxal (GO) and methylglyoxal (MGO), are believed to be important must be made not to improve intradialytic complications by providing
intermediates in the formation of advanced glycation endproducts the patient with a sodium load, resulting in increased interdialytic
(AGEs) and might be linked to the development of long-term compli- complications. Key word: Dialysis
cations associated with peritoneal dialysis. We demonstrated that these
a-oxoaldehydes, when incubated in vitro with albumin, led to the
formation of specific AGE-fluorescence (Ex 350 nm, Em 435 nm). We Cytokine removal with continuous veno-venous hemofiltration
also quantified 3-DG, GO and MGO in glucose-based heat-sterilized (CVVH) in sepsis: effect of increasing blood flow (QB). A. De Vries1,
commercial PD-fluids with a newly developed HPLC method, based R. Vanholder1, J. De Sutter2, J. Philippe´3, F. Colardyn and 2, N. Lameire1.
on derivatization with 1,2-diamino-4,5-dimethoxybenzene and fluo- Renal Division1, Intensive Care Unit2, Department of Clinical Biology3,
rescence detection. To test whether these a-oxoaldehydes are formed University Hospital, Gent, Belgium. High volume CVVH has a benefi-
during heat-sterilization, we also investigated the concentrations in cial effect on hemodynamic and respiratory function in animal models
laboratory made filter-sterilized PD-fluids. The analysis revealed that of sepsis, which has been attributed to convective removal of inflam-
during heat sterilization high concentrations of 3-DG, GO and MGO matory mediators. In human sepsis, pro-inflammatory cytokines can
were formed as compared with filter-sterilized PD fluids. be removed by ultrafiltration, but generally without a concommittant
fall of their serum concentration. Optimalization of the QB may lead
to more efficient convective removal. In addition, little is known about
3-DG (lM) MGO (lM) GO (lM) the elimination of inhibitors of inflammation. We therefore studied
the effect of QB on the removal kinetics of pro- and anti-inflammatoryHeat- Filter- Heat- Filter- Heat- Filter-
cytokines in patients with sepsis. 15 patients (9M, age 35–75y) withst. st. st. st. st. st.
septic shock (ACCP/SCCM Consensus Conference 1997) and acute
Dianealt 1.36% 319 2.1 3.8 0.1 3.2 0.5 renal failure were studied during the first 24h of CVVH (BSM-22,
Dianealt 2.27% 472 2.8 5.1 0.2 6.7 0.3 AN69 membrane). At t 5 12 the membrane was changed and QB was
Dianealt 3.86% 765 4.5 7.3 0.3 10.0 1.1 switched from 100 to 200 ml/min or vice versa. Concentrations in pre-
and postfilter serum and in ultrafiltrate of tumor necrosis factor-a
(TNFa), interleukin-1b (IL-1b), IL-6, soluble TNF receptors (sTNFR-I
and -II), IL-1 receptor antagonist (IL-1ra) and IL-10 were measuredWe also demonstrated that heat-sterilized PD-fluids, when incubated
at t 5 0, 1, 6, 12, 13, 18, 24 and a mass balance was calculated. Thewith albumin, developed much more AGE-fluorescence as compared
total removed mass/mkn (TRM 5 mass/min in prefilter plasma 2 mass/with filter-sterilized fluids. We conclude that reactive a-oxoaldehydes
are formed during the process of heat-sterilization and that these inter- min in postfilter plasma) and the mass/min removed in the ultrafiltrate
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(UFM) were compared for QB 5 100 and 200 ml/min. IL-10, sTNFR-I p 5 0.007). there was no significant difference in glomerular CTGF
expression between younger and older rats, or between UNX and 2kand sTNFR-II ultrafiltrate levels were low or undetectable. For the
other cytokines, the UFM was 19 to 46% of the TRM, the rest being rats, despite development in SHR of focal glomerulosclerosis (FGS)
at 17 and 32 weeks post UNX, and despite increase of glomerarremoved by membranes adsorption. The UFM for QB 5 200 ml/min
as compared to 100 ml/min rose with 82% for TNAa, 40% for IL-1b, a-SMA expression at 32 weeks post UNX. Glomeruli were negative
for TGFb1 throughout the experiment. In contrast, until 17 weeks post70% for IL-6 and 67% for IL-1ra. The TRM rose for all cytokines,
from 25% for sTNFR-I to 55% for IL-1ra. The absolute rise was clearly UNX, tubulointerstitial CTGF and a-SMA expression levels remained
unchanged, and until then, there was no difference between UNX-in excess of the rise in the UFM, indicating that also the removal by
adsorption increased. We conclude that cytokine removal is substan- and 2k rats, or between SHR and WKY. At 32 weeks post UNX,
however, tubulointerstitial CTGF mRNA and a-SMA and TGFb1tially higher with a QB of 200 ml/min as compared to 100 ml/min, due
to both higher ultrafiltration and membrane adsorption. However, protein expression were upregulated in UNX-SHR (5-fold over base-
line, p , 0.001), but not in 2k SHR, nor in UNX or 2k WKY. Conclu-since pro- and anti-inflammatory cytokines are removed to the same
extent, their patho-physiologic impact may not be affected by this sion: In SHR, that develop FGS after UNX, CTGF is expressed in
glomeruli at a higher baseline level than in WKY, a strain relativelyincrease in QB.
protected from FGS. The strong induction of CTGF in the tubulointer-
stitial compartment during the later phase of renal injury after UNX
in SHR is associated with tubulo-interstitial fibrosis and a-SMA accu-A cationic protein of staphylococcus aureus binds to endothelial cells:
its implications in Wegener’s granulomatosis. R.H. Brons, H.I. Bakker, mulation, and might be induced by overexpression of TGFb1.
R. van Wijk, A.C. Muller Kobold, C.G.M. Kallenberg, and J.W. Cohen
Tervaert. Department of Clinical Immunology, University Hospital
Groningen, The Netherlands. Introduction: The majority of patients Vascular dysfunction in adriamycin induced nephrotic syndrome is
attenuated by presence of a healthy kidney. G.J. Navis, E. de Boer,with Wegener’s granulomatosis (WG) are carriers of Staphylococcus
aureus (SA), a risk factor for relapses of the disease. Previously we J.H. Buikema, P.E. de Jong, and D. de Zeeuw. Departments of Nephrol-
ogy and Clinical Pharmacology, University Hospital Groningen. Indemonstrated that patients with WG have antibodies to a cationic
protein of SA, Staphylococcal acid phosphatase (SAcP). Yousif et al proteinuric renal disease cardiovascular morbidity and mortality is
extremely high. It is assumed that vascular dysfunction in renal diseasedemonstrated that SAcP has affinity for rat glomerular structures and
when used in a rat kidney perfusion model causes mild glomerulone- is multifactorial. Hemodynamic factors such as hypertension and meta-
bolic factors such as hyperlipidemia are implicated. To assess whetherphritis (GN). We hypothesize that, in WG, SAcP may induce mild
vasculitis and GN, which are aggravated in the presence of ANCA. compromized vascular function is further impaired by proteinuria (or
its metabolic consequences), we studied in vitro vascular function inIn the present study we investigated whether SAcP binds to in vitro
cultured human umbilical cord vein endothelial cells (EC) and human adriamycin nephrotic rats with different severity of proteinuria. Severe
proteinuria was induced by a single intravenous injection of adriamycinglomerular EC and whether this binding is charge-dependent. Materi-
als and Methods: For the binding of SAcP to EC, different concentra- (ADR, 1.5 mg.kg21); leading to bilateral adriamycin proteinuria (BAP).
Mild to modest proteinuria was induced similarly with concomitant,tions of SAcP (0, 15 and 30 mg/ml) were tested in an EC-ELISA.
Binding was detected in 3 different ways: 1) by use of a monoclonal temporary clipping of one renal artery to allow for protection of one
kidney from exposure to ADR, leading to unilateral adriamycin pro-antibody directed against SAcP, 2) by measuring the enzymatic activity
of SAcP bound to EC and 3) by biotinylation of SAcP. To further teinuria (UAP). BAP and UAP were compared to untreated rats
(CON) and to double-clipped adriamycin-treated rats (DCA) to con-study charge-based interaction we incubated EC with both 15 mg/ml
SAcP and different concentrations of a negatively charged protein, trol for direct vascular effects of ADR. To study the vascular function,
endothelium-dependent (Ach) and -independent vasodilation (NO3)heparin (medium, 0.5 IU/ml, 1.0 IU/ml and 5 IU/ml). All values are
expressed as OD values. Results: We found that SAcP was able to was studied in isolated aortic rings, 12 weeks after induction of protein-
uria.bind to both human umbilical cord vein and glomerular EC in a dose-
dependent way (medium; 0.276 6 0.04, 9 mg/ml SAcP; 1.255 6 0.04,
18 mg/ml SAcP; 1.492 6 0.05 and 36 mg/ml SAcP; 1.785 6 0.044). SAcP
could bind to EC when incubated in medium without heparine but BAP UAP DCA CON
when 0.5 IU/ml heparine was added to the medium the binding of
N 11 10 11 11SAcP could be completely inhibited (1.374 6 0.11 vs 0.179 6 0.02).
BW Gr 481610# 490 67# 481 614# 522 68Conclusion: SAcP can bind to EC via a charge interaction. These
SBP MmHg 14267 143 65 139 63 140 63results are consistent with the hypothesis that SAcP may play a role
Uprot mg/24 h 511663#* 222 634# 89 622#* 30 67in the development of vasculitis and GN in patients with WG.
Pchol lM/l 5.960.7#* 3.1 60.2# 2.3 60.2* 2.2 60.1
NO3max %PE 27165 28767# 27865 26663
Achmax %PE 22563#* 24768# 22664#* 23767CTGF in hypertensive nephrosclerosis of the SHR-UNX model. Y.
Achmax %NO3 3664#* 53 67 33 65#* 53 68Ito1, J. Aten1, R. Bende1, A. Chand1, L. Kley2, J. Joles2, T. Rabelink2, J.
Parameters at the end of the study. Means 6 SEM. NO3max 5 max. relaxationWeening1, and R. Goldschmeding3. Depts of Pathology1, AMC, Amster-
during NaNO2 as % of precontraction during phenylephrine (%PE), Achmax 5dam and of Nephrology2 and Pathology3, UMC, Utrecht, The Nether-
max. relaxation during acetylcholine as % of either PE or NO3 (%NO3).lands. Aim: To study CTGF expression during development of
*P , 0.05 vs. UAP, #P , 0.05 vs. CON.nephrosclerosis in uninephrectomised spontaneously hypertensive rats
(SHR-UNX). Methods: SHR and WKY rats were uninephrectomized
or sham operated when 8 weeks old, and evaluated (histology, CTGF The acetylcholine (Ach) induced relaxation was significantly impaired
mRNA in situ hybridisation, a-SMA and TGFb1 immunohistology, in BAP and DCA, demonstrating the vasculotoxic effects of ADR per
blood pressure, renal function and plasma lipids) at time of surgery, se, even in the absence of proteinuria. This seemed not be due to
and 17 and 32 weeks post UNX. Results: Systolic blood pressure was decreased relaxatory capacities, because NaNO2-induced relaxation
increased in SHR and not affected by UNX. Proteinuria increased in these rats was, if anything, increased rather than decreased. Since
gradually in the UNX SHR, but not in the 2 kidney (2k)SHR. At 32 Ach-induced relaxation in the rat aorta is largely mediated by NO
weeks after UNX plasma creatinin values were not significantly differ- released from the endothelium, the preserved response to NaNO2
ent between UNX- and 2k SHR. In both, plasma cholesterol and indicates that ADR affects vascular function at the level of endothe-
plasma triglycerides were slightly raised. At that time, kidney weight lium. Surprisingly, in UAP, despite the significant proteinuria and
and kidney weight over body weight were higher in UNX SHR than hypercholesterolemia and despite prior exposition of the aorta to
in 2k SHR and UNX WKY, and in 2k SHR than in 2k WKY. Already at ADR, Ach-induced vasodilatation was not affected at all. We were
the time of UNX, when no lesions were visible yet, a higher glomerular not able to relate this better vascular function in UAP to the lesser
CTGF mRNA expression (located mainly in visceral and some parietal severity of proteinuria, as no correlation was present between protein-
uria (or cholesterol) and the degree of impairment of Ach-inducedepithelial cells) was observed in SHR than in WKY rats (1.58-fold,
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relaxation. In conclusion, in adriamycin nephrotic rats distinct vascular correlated directly to plasma Lp(a) concentration (p , 0.0001) in all
subjects. The present results demonstrate that increased synthesis,dysfunction is present, located at endothelial level. Remarkably, in
UAP the endothelium is protected from dysfunction due to direct rather than decreased catabolism causes elevated plasma Lp(a) concen-
trations in the nephrotic syndrome.ADR-toxicity. The mechanism underlying this phenomenon remains
to be explored.
Endothelin A receptor blockade prevents hypertension, cerebral
edema and proteinuria in stroke-prone hypertensive rats. E.L.A.T-cell activation and TCR V-beta skewing in Wegener’s granulomato-
sis: indications for activation by superantigens. E.R. Popa, C.A. Stege- Blezer, K. Nicolay, R.C. Goldschmeding, H.A. Koomans, T.J. Rabelink,
and J.A. Joles. Nephrology and Pathology, University Hospital Utrechtman, N.A. Bos, C.G.M. Kallenberg, and J.W. Cohen Tervaert. Depts. of
Clinical Immunology and Nephrology, University Hospital, Groningen; and In vivo NMR, Bijvoet Center, Utrecht University, The Netherlands.
To explore the importance of endothelin-1 in the development andDept. of Histology and Cell Biology, University of Groningen, The
Netherlands. Accumulating evidence suggests that cellular immunity maintenance of severe hypertension and target-organ damage we used
salt-loaded stroke-prone spontaneously hypertensive rats (SHRSP), ais involved in the pathophysiology of Wegener’s granulomatosis (WG).
Recently, we reported on a persisting, significantly increased level of model of severe hypertension-related encephalopathy and nephropa-
thy. Chronic treatment with the endothelin receptor subtype A (ETA)T-cell activation during complete remission in WG (Popa et al., JASN
1997; 8:543A). Based on our previous finding that chronic nasal carriage antagonist A127722 was initiated at the start of salt-loading or after
manifestation of cerebral edema. SHRSP were subjected to 1% NaClof Staphylococcus aureus correlates with an increased frequency of
disease relapses in WG and our recent report on staphylococcal super- intake. In the A35EARLY and A70EARLY-groups, treatment with A127722
(35 and 70 mg/kgxday, respectively) was synchronized with salt-loading.antigens (SAgs) as a risk factor in disease reactivation (Cohen Tervaert
et al., JASN 1997; 8:533A), we hypothesized that staphylococcal SAgs In the A35LATE and A70LATE-groups, treatment with A127722 was initi-
ated after the first observation of cerebral edema with T2-weightedplay a role in the persistent activation of T cells in this disease. Here,
we analyzed by FACS the activation of peripheral blood T cells from MRI. In untreated controls, median survival was 54 days after start of
salt-loading. Under early-onset A127722 treatment, median survival27 WG patients (11 active, 16 quiescent) and 16 healthy controls, using
monoclonal antibodies to the activation markers CD25 and HLA-DR. increased to 233 days in A35EARLY and to 124 days in A70EARLY. The
development of cerebral edema was prevented and systolic blood pres-In the same patients we studied as a potential marker of superantigenic
T-cell activation the expansion of T cells expressing the SAg-specific sure and proteinuria were dose-dependently reduced. However, all
rats in the A70EARLY-group developed haemorrhages in the basal gangliaTCR V-beta (Vb) molecules 2, 5.3, 17 and 21.3. Confirming our previ-
ous results, we found a significantly increased percentage of activated shortly before death. Late-onset A127722 treatment failed to affect
survival, systolic blood pressure, or proteinuria. Cerebral edema wasT cells in WG patients as compared to controls (CD4 subset P 5
0.0013; CD8 subset P 5 0.0138). In 21/27 patients and in 4/16 controls reduced, but was not as low as in the early-onset treatment group.
In SHRSP with cerebral edema, A127722 did not prolong survival,we found expansions of T-cell subsets expressing one of the above Vb
elements (P 5 0.0012) We further investigated the relation between although development of hypertension, cerebral edema and protein-
uria were prevented when A127722 was initiated at the start of salt-T-cell activation and the occurrence of T-cell expansions. 12/27 patients
had an elevated level of activated T cells. Nine of these 12 patients loading. This suggests that endogenous ET-1 participates importantly
in the development but barely in the maintenance of malignant hyper-also had expansions of one or more T-cell subsets expressing the above
Vb molecules. 15/27 patients had normal levels of activated T cells (as tension and target-organ damage in this model.
compared with healthy controls) and 12 of these patients had T-cell
subset expansions. Thus, the frequency of T-cell subset skewing did
not differ significantly in patients with increased numbers of activated
Proteinuria Systolic blood pressure
[mg/day] [mm Hg]T cells as compared to patients with normal numbers of activated T Median
survivalcells (P 5 1.0). In summary, expansions of T-cell subsets expressing
n [days] 4 Wk 12 Wk Terminal 4 Wk 12 Wk TerminalSAg-specific Vb molecules were found significantly more often in WG
patients than in controls. The occurrence of T-cell expansions did not Control 6 54 109 6 54 — 317 6 17 257 6 10 — 270 6 12
correlate with increased T-cell activation. We hypothesize that T-cell [32–80]
A35E 7 233 38 6 3* 187 6 83 359 6 5 202 6 12* 248 6 7 214 6 19*expansions persist from previous activation events.
[92–321]* (6) (6) (7)
A70E 7 124 37 6 1* 29 6 7† 13 6 4† 180 6 9* 182 6 12† 178 6 15*
[97–169]* (7) (6) (7)Evidence for increased synthesis of Lipoprotein(a) in the nephrotic
A35L 4 66 — — 436 6 114 — — 272 6 9syndrome. M.G.M. de Sain-van der Velden, D.J. Reijngoud, G.A. [54–74]
Kaysen, M.M. Gadellaa, H.A.M. Voorbij, F. Stellaard, H.A. Koomans, A70L 4 54 — — 198 6 13 — — 258 6 8
and T.J. Rabelink. Dept. of Nephrology & hypertension and Clinical [51–55]
Chemistry, University Utrecht, The Netherlands. Dept. of Medicine &
*p , 0.05 vs control; †p , 0.05 vs 35 mg/kg/day. E5 early; L 5 late.Dept. of Nephrology, UC Davis, Davis, CA. Laboratory of Nutrition
and Metabolism and Laboratory of Metabolic Disorders, University
Hospital Groningen, The Netherlands. In patients with the nephrotic Key word: fysiologie
syndrome markedly increased levels of Lipoprotein (a) [Lp(a)] concen-
tration have been frequently reported and it has been suggested that
this may contribute to the increased cardiovascular risk in these pa- Is variability in drug intake involved in differences in long term antipro-
tients. The mechanism is however not clear. In the present study we teinuric efficacy in adriamycin nephrotic rats? H. Bos, F.M. Wachters,
measured in vivo fractional synthesis rate (FSR) of Lp(a) using incorpo- G.J. Navis, R.H. Henning, P.E. de Jong, and D. de Zeeuw. Department
ration of the stable isotope 13C valine. Under steady state conditions of Clinical Pharmacology and Department of Nephrology, University
FSR equals fractional catabolic rate (FCR) of Lp(a) was estimated in of Groningen, The Netherlands. Interindividual variability in antipro-
5 patients with the nephrotic syndrome and compared with 5 control teinuric response to treatment is considerable in human as well as
subjects. The mean plasma Lp(a) concentration of the patients (1749 experimental renal disease. As antiproteinuric efficacy predicts long
6 612 mg/L) was higher than controls (553 6 96 mg/L). Two patients term renoprotection, identification of the sources of response variabil-
were heterozygous for apo(a) (range: 19–30 kringle IV domains) while ity would be useful. For long term intervention studies in rats, adding
all control subjects were each homozygous with regard to apo(a) pheno- drug to the drinking water is convenient, but differences in intake
type (range: 18–28 kringle IV domains). The FCR of Lp(a) was compa- might induce response variability. To test whether variability in drug
rable between controls (0.072 6 0.032 pools/day) and patients (0.064 intake is involved in interindividual differences in response we studied
6 0.029 pools/day) despite the wide variance in plasma concentration. the antiproteinuric effect of lisinopril administered in a strictly stan-
This implies that differences in Lp(a) levels are caused by differences dardized way: a fixed dose of 8 mg/kg in 3 ml glucose 5% offered once
daily in adriamycin nephrotic rats (n 5 18). Rats tend to drink thisin synthesis rate. Indeed, the absolute synthetic rate (ASR) of Lp(a)
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immediately, so intake can be verified by inspection. Thus, rats in Hoenderop, A. Hartog, P.H.G.M. Willems, and R.J.M. Bindels. Depart-
ments of Biochemistry and Cell Physiology, University of Nijmegen, Thewhom intake of the drug was incomplete (n 5 9) could be excluded
from the analysis, as were the two rats who died during the experiment. Netherlands. Hormones such as parathyroid hormone and vasopressin
stimulate active Ca21 reabsorption in the distal part of the nephron.For reference we also studied the antiproteinuric effect of lisinopril
administered conventionally (i.e. 75 mg/l dissolved in drinking water Earlier studies suggest that these stimulatory effects are mediated
through stimulation of adenylyl cyclase, accumulation of cAMP andto which rats have free access (n 5 6)). Intake in this group varied
from 5.2 to 8.8 mg/kg/day (median 7.3). Treatment started after stabili- subsequent activation of protein kinase A. In the present study, the
effect of adenosine on transcellular Ca21 transport was investigatedzation of proteinuria (i.e. 6 weeks after injection of adriamycin 1.5 mg/
kg) and was continued for 6 weeks. Results after 6 weeks of treatment in immunodissected rabbit connecting and cortical collecting tubules
cultured to confluency on permeable supports. Addition of adenosine(median and range):
to the apical side, dose-dependently increased Ca21 reabsorption to a
maximum of 110 6 4 nmol.h21.cm22 (222 6 8% of basal) reached at
Standardized (n 5 7) Reference (n 5 6) a concentration of 10 mm. In addition, the hormone dose-dependently
increased the rate of cAMP formation, which suggests the involvementTreatment Treatment
of the A2 adenosine receptor. The specific A2 receptor agonist CGSPretreatment % change Pretreatment % change
21680 (10 mm), however, did not stimulate Ca21 transport, while readily
Body weight 345 13 351 13 increasing the rate of cAMP formation. On the contrary, the specific
gram 314–357 16; 27 295–381 115; 12 A1 receptor agonist CPA (100 mm) maximally stimulated Ca21 transport
Proteinuria 862 265 822 266 to 228 6 12% without significantly affecting the rate of cAMP forma-
mg/24 h 824–1027 242; 289 627–1088 210; 294 tion. The involvement of the A1 receptor was further supported by
MAP 133 234 125 236 the inhibitory effect of the A1 antagonist DPCPX and the lack of effect
mmHg 131–134 230; 236 111–135 224; 244 of the A2 antagonist DMPX on adenosine-stimulated Ca21 transport.
Activation of the A1 receptor is known to lead to intracellular Ca21
mobilization and protein kinase C activation. Abolishing the increaseThus, even with strictly standardized drug administration, interindivid- in intracellular Ca21 with the Ca21-chelator BAPTA did not inhibitual variability in the antiproteinuric effect of lisinopril was consider- the stimulatory effect of adenosine on Ca21 transport. Similarly, down-able, although variability tended to be somewhat smaller than in the regulation of protein kinase C by culturing the cells in the presencereference group (p 5 0.052). We conclude that variability in drug intake of the phorbol ester TPA (0.1 mm) for 5 days was without any effectcan not fully explain the variability in the antiproteinuric response on adenosine-stimulated Ca21 reabsorption. These results suggest thatof lisinopril in long term intervention studies in rats. Interindividual adenosine interacts with an apical A1 receptor to stimulate Ca21 trans-differences in the severity of prior renal damage may be involved in the port via a hitherto unknown cAMP-independent intracellular pathway.differences in therapy responsiveness; this remains to be investigated. Key word: Physiology
Amiloride attenuates the natriuresis of felodipine and the combination Insulin’s acute antinatriuretic effects, but not insulin resistance, contrib-of these drugs leads to kaliuresis. H.W. van Hamersvelt, H.J. Kloke, ute to salt sensitivity. J.C. ter Maaten, S.J.L. Bakker, E.H. Serne´, P.M.J.F.M. Wetzels, and F.Th.M. Huysmans. Dept. of Nephrology, Univer- ter Wee, A.J.M. Donker, and R.O.B. Gans. Dept. of Medicine, Universitysity Hospital, Nijmegen, The Netherlands. We have previously shown Hospital Vrije Universiteit, Amsterdam, The Netherlands. Insulin resis-that part of the acute natriuresis on the dihydropyridine calcium entry tance has been associated with hypertension and salt sensitivity. It hasblocker felodipine (FEL) is due to a distal tubular effect, which can been suggested that insulin-induced renal vasodilation may decreasebe antagonized by exogenous aldosterone. This suggests an influence proximal sodium reabsorption through “pressure natriuresis.” Like-of FEL on the distal tubular sodium channel (ENaC) and we therefore wise, impaired insulin-mediated renal vasodilation may contribute tostudied the influence of amiloride (AMI)-a blocker of ENaC on the abnormal proximal sodium handling and link insulin resistance to saltnatriuretic effect of FEL. Twelve healthy, normotensive volunteers
sensitivity. In two groups of ten relatively insulin resistant (IR) andreceived 180 min FEL infusion (14.4 mg/kg) after one week of random-
insulin sensitive (IS) normal subjects (M value 4.9 6 0.7 and 10.3 6ized, crossover, single blind pretreatment with AMI 5 mg bid or placebo
0.6 mg/kg/h, respectively) we assessed the effects of two sequential(PL). Continuous insulin and PAH infusions were used to estimate
doses of insulin (50 and 150 mU/kg/h) on renal hemodynamics, usingGFR and RPF, respectively. AMI pretreatment significantly decreased
the euglycemic clamp technique and clearances of 131I-Hippuran andbody weight from 76.7 6 2.0 to 75.8 6 2.0 kg, and increased PRA 125I-Iothalamate, sodium and lithium. Time-control experiments werefrom 1.1. 6 0.3 to 2.5 6 0.3 nmol/L/hr and plasma aldosterone (PAC)
performed and salt sensitivity was determined using a diet method.from 0.6 6 0.1 to 2.0 6 0.5 nmol/L. The absolute changes induced by
During physiological hyperinsulinemia, renal plasma flow and glomeru-FEL infusion are shown in the Table:
lar filtration rate increased less in IR than IS subjects (P 5 0.026 and
P 5 0.002, respectively). In both groups, fractional sodium excretion
decreased, and estimated distal sodium reabsorption increased, to aDGFR DRPF DFENa DFEK
similar extent. Estimated proximal sodium reabsorption decreasedml/min ml/min % %
5.0% in IR subjects (P 5 0.006) but only 2.4% in the IS subjects. The
PL1FEL 9 64 165626 1.560.4 22.761.7 changes in estimated proximal sodium reabsorption correlated with
AMI1FEL 1 62 65617** 0.560.2** 2.461.5* the changes in glomerular filtration rate (r 5 0.53, P 5 0.016) but
not with changes in renal plasma flow. Salt sensitivity, defined as theMeans 6 SEM. FENa and FEK 5 fractional sodium and potassium excretions.
*P , 0.05 and **P , 0.01 compared to PL1FEL difference in mean arterial blood pressure between a low- and high-
sodium diet, varied from 214.9 to 113.3 mmHg. Salt sensitivity did
not correlate with the insulin-mediated glucose uptake and showed aConclusion: In these healthy volunteers, AMI induced some volume
weak inverse correlation with the changes in fractional sodium excre-depletion appearing from the lower body weight and higher PRA.
tion (r 5 20.38, P 5 0.10). Salt sensitivity showed a positive correlationUnder these circumstances, the renal vasodilating and natriuretic effect
with insulin-induced changes in estimated proximal sodium reabsorp-of FEL were attenuated. However, our data do not support an effect
tion (r 5 0.49, P 5 0.028). Conclusions: acute renal effects of insulinof FEL on ENaC, since FEL induced a kaliuresis despite ENaC block-
differ between IR and IS subjects, but do not directly link insulinade with AMI. The fact that FEL induced kaliuresis only after AMI
resistance to salt sensitivity. Insulin’s acute antinatriuretic effects itself,pretreatment could be due to the elevation of PAC induced by AMI.
however, may contribute to salt sensitivity.Key word: renal physiology
Lipopolysaccharide induces hyporeactivity to norepinephrine and ace-Adenosine stimulation of Ca21 reabsorption is mediated by an apical
A1 receptor in rabbit connecting and cortical collecting tubules. J.G.J. tylcholine in rat isolated renal arteries. H.A. Piepot, A.A. van Lambal-
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gen, A.B.J. Groeneveld, and P. Sipkema. Institute for Cardiovascular responses. Cumulative dose-response relations to norepinephrine (NE)
and the endothelium-dependent vasodilator acetylcholine (ACh) wereResearch Vrije Universiteit (IcaR-VU), Amsterdam, The Netherlands.
obtained. After 2 hours incubation with LPS, no effect was seen onDuring septic shock, caused by endotoxin (lipopolysaccharide, LPS),
NE-induced contractions whereas a significant reduction (p , 0.05) inrenal dysfunction is observed. Changes in systemic hemodynamics dur-
ACh-induced relaxation was seen (max. relaxation was 62.2 6 4.6%ing shock and/or local effects of LPS on renal hemodynamics may
and 39.2 6 3.7% in control-resp. LPS-incubated renal arteries). Afterunderlie the renal impairment. In this study we tested, in an in vitro
20 hours incubation with LPS a significant (ANOVA, p , 0.05)setup, the direct effects of LPS on renal vasoreactivity. Renal arteries
rightward-shift of the dose-response relation to NE was observed indi-(300–350 mm) from male rats (250–300 gr, n 5 8) were isolated under cating a decreased sensitivity to NE. Responses to ACh were almost
sterile conditions and cut into 4 segments. Segments were incubated abolished in comparison to time-matched controls (max. relaxation
for 2 and 20 hours in sterile DMEM containing E. coli LPS (O127:B8, was 36.3 6 8.6% and 7.3 6 3.4% in control-resp. LPS-incubated renal
50 mg/ml); time-matched controls were incubated in DMEM without arteries). This study supports the concept that LPS directly induces
LPS. After incubations, control- and LPS-incubated segments were changes in vascular reactivity, which may be involved in renal dysfunc-
tion during septic shock. Key word: physiologyplaced in a dual wire-myograph for measurement of isometric force-
